Medlive Technology Co., Ltd. (HKG:2192)
Hong Kong
· Delayed Price · Currency is HKD 12.48
+0.18 (1.46%)
May 30, 2025, 11:45 AM HKT
Medlive Technology Market Cap
Medlive Technology has a market cap or net worth of 9.01 billion as of May 29, 2025. Its market cap has increased by 42.53% in one year.
Market Cap
9.01B
Enterprise Value
4.68B
Revenue
594.29M
Ranking
n/a
PE Ratio
27.01
Stock Price
12.48
Market Cap Chart
Since July 15, 2021, Medlive Technology's market cap has decreased from 21.40B to 9.01B, a decrease of -57.87%. That is a compound annual growth rate of -20.00%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 29, 2025 | 9.01B | 23.99% |
| Dec 31, 2024 | 7.27B | 17.93% |
| Dec 29, 2023 | 6.16B | 0.75% |
| Dec 30, 2022 | 6.12B | -68.46% |
| Dec 31, 2021 | 19.40B | -9.33% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeiGene | 223.40B |
| Hansoh Pharmaceutical Group Company | 154.89B |
| JD Health International | 132.48B |
| WuXi Biologics | 104.77B |
| Innovent Biologics | 102.44B |
| CSPC Pharmaceutical Group | 87.09B |
| Sino Biopharmaceutical | 79.09B |
| Akeso | 78.04B |